Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intravenous pamidronate in osteogenesis imperfecta type VII.

Calcified tissue international - 1 Mar 2009

Cheung Moira S, Glorieux Francis H, Rauch Frank

Abstract excerpt

Cyclical intravenous treatment with pamidronate is widely used to treat osteogenesis imperfecta (OI) types I, III, and IV, which are due to dominant mutations affecting collagen type I alpha chains. There is no information about the effects of pamidronate in children with OI type VII, an autosoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Chemical Analysis
Share to Bone Density Conservation Agents
Share to Collagen Type I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Collagen Type I, alpha 1 Chain

Share to Diphosphonates

Share to Fractures, Bone

Share to Injections, Intravenous

Share to Osteogenesis Imperfecta

Source

Identifiers

PMID: 19137231
DOI: 10.1007/s00223-008-9211-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19137231-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Intravenous pamidronate in osteogenesis imperfecta type VII.PMID 19137231Read ↗

Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.Semantic proximity Read ↗

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response.Semantic proximity Read ↗

Intravenous pamidronate treatment in osteogenesis imperfecta.Semantic proximity Read ↗

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.Semantic proximity Read ↗

Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.Semantic proximity Read ↗

Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta.Semantic proximity Read ↗

Natural History of Hyperplastic Callus Formation in Osteogenesis Imperfecta Type VSemantic proximity Read ↗

Long-term follow-up in osteogenesis imperfecta type VI.Semantic proximity Read ↗

Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.Semantic proximity Read ↗

Clinical management of osteogenesis imperfecta.Semantic proximity Read ↗

Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.